Testing digoxin for medulloblastoma that came back in kids and young adults
Original title: Digoxin Medulloblastoma Study
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage test to see if the drug works.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a drug called digoxin in young people whose medulloblastoma came back.
Who this trial is for. This trial is for children and young adults with medulloblastoma that came back. It is for the non-SHH, non-WNT types of this tumor. The trial is testing how well a drug called digoxin works.
Where it stands. This trial has not reported results. It is measuring how well digoxin works against these tumors. The answer is not in yet.
What this means, and what it doesn't
What it could mean: A drug used for other health problems is being tested against this tumor. Nobody knows yet if it helps. Someone who fits this picture could ask their care team about the trial.
What it doesn't mean: This does not mean digoxin treats medulloblastoma. A trial is a test, not a proven treatment. Joining one is not a promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, August 26, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.